MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer
Authors:
Open Access
- 1 January 2018
- journal article
- research article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 17
Abstract
MicroRNAs have been reported to play an important role in diverse biological processes and progression of various cancers. MicroRNA-29a has been observed to be downregulated in human lung cancer tissues, but the function of microRNA-29a in lung cancer has not been well investigated. In this study, we demonstrated that the expression levels of microRNA-29a were significantly downregulated in 38 pairs of lung cancer tissues when compared to adjacent normal tissues. Overexpression of microRNA-29a inhibited the activity of cell proliferation and colony formation of lung cancer cells, H1299 and A549. Furthermore, microRNA-29a targeted NRAS proto-oncogene in lung cancer cells. In human clinical specimens, NRAS proto-oncogene was highly expressed in human lung cancer tissues compared to normal tissues. More interestingly, microRNA-29a also sensitizes lung cancer cells to cisplatin (CDDP[Please replace “CDDP” with its expansion in the abstract and also provide expansion for the same in its first occurrence in text, if appropriate.]) via its target, NRAS proto-oncogene. Thus, our results in this study demonstrated that microRNA-29a acted as a tumor suppressor microRNA, which indicated potential application of microRNAs for the treatment of human lung cancer in the future.Keywords
This publication has 31 references indexed in Scilit:
- SOX7 is down-regulated in lung cancerJournal of Experimental & Clinical Cancer Research, 2013
- Lung cancer biomarkers: State of the artJournal of Carcinogenesis, 2013
- Genetic alterations in the RAS/RAF/mitogen‐activated protein kinase and phosphatidylinositol 3‐kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinomaCancer, 2010
- A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenesOncogene, 2006
- MicroRNAsCell, 2004
- Constitutive NF-κB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathwayLeukemia, 2003
- Oxidized Phospholipid-Induced Endothelial Cell/Monocyte Interaction Is Mediated by a cAMP-Dependent R-Ras/PI3-Kinase PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Metastasis suppressors alter the signal transduction of cancer cellsNature Reviews Cancer, 2003
- The Phosphoinositide 3-Kinase PathwayScience, 2002
- Identification of Insulin Receptor Substrate 1 (IRS-1) and IRS-2 as Signaling Intermediates in the α6β4 Integrin-Dependent Activation of Phosphoinositide 3-OH Kinase and Promotion of InvasionMolecular and Cellular Biology, 2001